Bicycle Total Assets from 2010 to 2024

BCYC Stock  USD 20.40  0.45  2.26%   
Bicycle Therapeutics' Total Assets are increasing over the years with slightly volatile fluctuation. Overall, Total Assets are expected to go to about 625.1 M this year. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2017-12-31
Previous Quarter
1.1 B
Current Value
996.7 M
Quarterly Volatility
273.8 M
 
Covid
Check Bicycle Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bicycle Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 1.5 M, Interest Income of 14.7 M or Discontinued Operations of 0.0, as well as many indicators such as Price To Sales Ratio of 40.62, Dividend Yield of 0.0 or PTB Ratio of 1.65. Bicycle financial statements analysis is a perfect complement when working with Bicycle Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Bicycle Therapeutics Correlation against competitors.
For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.

Latest Bicycle Therapeutics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Bicycle Therapeutics over the last few years. Total assets refers to the total amount of Bicycle Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bicycle Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Bicycle Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bicycle Therapeutics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 595.34 M10 Years Trend
Slightly volatile
   Total Assets   
       Timeline  

Bicycle Total Assets Regression Statistics

Arithmetic Mean174,711,613
Geometric Mean57,613,327
Coefficient Of Variation131.36
Mean Deviation188,267,966
Median74,001,000
Standard Deviation229,497,665
Sample Variance52669.2T
Range613.3M
R-Value0.86
Mean Square Error14654.9T
R-Squared0.74
Significance0.000037
Slope44,193,376
Total Sum of Squares737368.5T

Bicycle Total Assets History

2024625.1 M
2023595.3 M
2022410.6 M
2021479.8 M
2020161.2 M
2019110.2 M
201881.6 M

Other Fundumenentals of Bicycle Therapeutics

Bicycle Therapeutics Total Assets component correlations

0.970.96-0.970.860.840.860.791.00.970.960.87-0.990.980.920.92
0.970.99-0.920.810.770.880.630.970.960.930.89-0.980.990.920.93
0.960.99-0.90.750.810.920.670.960.970.910.89-0.961.00.930.95
-0.97-0.92-0.9-0.94-0.86-0.84-0.76-0.96-0.96-0.98-0.840.95-0.94-0.86-0.9
0.860.810.75-0.940.680.650.650.860.830.930.69-0.870.80.710.73
0.840.770.81-0.860.680.830.850.830.860.830.83-0.780.820.840.91
0.860.880.92-0.840.650.830.590.860.950.80.74-0.810.910.790.94
0.790.630.67-0.760.650.850.590.790.70.740.72-0.740.70.780.73
1.00.970.96-0.960.860.830.860.790.970.950.87-0.990.980.920.92
0.970.960.97-0.960.830.860.950.70.970.930.84-0.940.980.880.96
0.960.930.91-0.980.930.830.80.740.950.930.85-0.950.930.860.87
0.870.890.89-0.840.690.830.740.720.870.840.85-0.890.890.960.9
-0.99-0.98-0.960.95-0.87-0.78-0.81-0.74-0.99-0.94-0.95-0.89-0.97-0.94-0.9
0.980.991.0-0.940.80.820.910.70.980.980.930.89-0.970.920.95
0.920.920.93-0.860.710.840.790.780.920.880.860.96-0.940.920.93
0.920.930.95-0.90.730.910.940.730.920.960.870.9-0.90.950.93
Click cells to compare fundamentals

About Bicycle Therapeutics Financial Statements

Bicycle Therapeutics stakeholders use historical fundamental indicators, such as Bicycle Therapeutics' Total Assets, to determine how well the company is positioned to perform in the future. Although Bicycle Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bicycle Therapeutics' assets and liabilities are reflected in the revenues and expenses on Bicycle Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bicycle Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Assets595.3 M625.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Bicycle Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bicycle Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bicycle Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bicycle Therapeutics Stock:
Check out the analysis of Bicycle Therapeutics Correlation against competitors.
For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bicycle Therapeutics. If investors know Bicycle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bicycle Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.19)
Revenue Per Share
0.716
Quarterly Revenue Growth
(0.50)
Return On Assets
(0.15)
Return On Equity
(0.27)
The market value of Bicycle Therapeutics is measured differently than its book value, which is the value of Bicycle that is recorded on the company's balance sheet. Investors also form their own opinion of Bicycle Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Bicycle Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bicycle Therapeutics' market value can be influenced by many factors that don't directly affect Bicycle Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bicycle Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bicycle Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bicycle Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.